Table 2.
Association between IMDC severity and CRP levels before and after treatment
| Characteristic | N | Initial CRP Median (IQR) |
p value | N | Post-treatment CRP Median (IQR) |
p value |
|---|---|---|---|---|---|---|
| Diarrhea grade | 0.015 | 0.238 | ||||
| 1-2 | 23 | 12.1 (5.3-31.4) | 38 | 3.4 (1.0-7.6) | ||
| 3-4 | 43 | 35.1 (9.6-69.0) | 61 | 4.1 (1.3-15.1) | ||
| Colitis grade | 0.013 | 0.183 | ||||
| 1 | 19 | 17.1 (7.8-28.9) | 23 | 2.6 (1.0-4.5) | ||
| 2-4 | 30 | 49.0 (12.1-82.4) | 52 | 4.4 (1.9-14.9) | ||
| Endoscopic presentation | 0.016 | 0.397 | ||||
| Active inflammation (ulcer ± non-ulcer inflammation) | 52 | 30.1 (9.1-72.4) | 81 | 2.6 (1.0-9.1) | ||
| Normal | 16 | 15.4 (5.9-23.8) | 21 | 3.8 (1.3-14.2) |
IMDC, immune-mediated diarrhea and colitis; CRP, C-reactive protein; IQR, interquartile range.
Mann-Whitney U test was used for analysis and reported as median and IQR.